Eli Lilly plans to pay up to $7 billion to purchase Kelonia Therapeutics
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...
Eli Lilly, a U.S. pharmaceutical corporation, and Kelonia Therapeutics, a privately held biotechnology business. Reached an agreement on Monday to...